Jove
Visualize
Contact Us

Related Experiment Videos

Assessing & preventing medication interactions.

Christy M Dunn1

  • 1Case Western Reserve University, Cleveland, OH, USA. cmd21@po.cwru.edu

Home Healthcare Nurse
|February 13, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

The unspoken epidemic.

Home healthcare nurse·2014
Same journal

Accountable care organizations and home care: strategies for success.

Home healthcare nurse·2014
Same journal

Understanding health literacy.

Home healthcare nurse·2014
Same journal

A day in the life of a Veteran Affairs home care case manager.

Home healthcare nurse·2014
Same journal

Breaches in infection control practices.

Home healthcare nurse·2014
Same journal

ISMP medication errors.

Home healthcare nurse·2014
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Polypharmacy, the use of multiple drugs, increases drug interaction risks. This article explains three drug interaction types and offers prevention strategies to improve patient safety.

Area of Science:

  • Pharmacology
  • Clinical Pharmacy
  • Drug Safety

Background:

  • Concurrent medication use is prevalent in managing complex health conditions.
  • The risk of adverse drug events escalates with the number of prescribed medications.
  • Understanding drug interactions is crucial for effective and safe pharmacotherapy.

Purpose of the Study:

  • To elucidate the mechanisms underlying three primary drug interaction classifications.
  • To provide actionable strategies for mitigating the incidence and severity of drug interactions.
  • To enhance healthcare provider knowledge on preventing adverse drug events.

Main Methods:

  • Review of pharmacological principles governing drug interactions.
  • Categorization of drug interactions based on pharmacokinetic and pharmacodynamic mechanisms.

Related Experiment Videos

  • Synthesis of clinical evidence and expert recommendations for prevention.

    • Main Results:

    • Detailed description of metabolic, pharmacokinetic, and pharmacodynamic drug interactions.
    • Identification of common drug combinations associated with significant interaction risks.
    • Evidence-based strategies for minimizing drug interactions, including dose adjustment and therapeutic substitution.

    Conclusions:

    • Drug interactions pose a significant threat to patient safety in polypharmacy.
    • Awareness of interaction types and proactive prevention are essential.
    • Implementation of recommended strategies can reduce adverse drug events and improve therapeutic outcomes.